Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus. (Q54530328)
Jump to navigation
Jump to search
scientific article published on 21 December 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus. |
scientific article published on 21 December 2013 |
Statements
Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus (English)
Gadintshware Gaoatswe
Lydia Lynch
Michelle A Corrigan
Jean O'Connell
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference